Cargando…
Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine
Influenza A viruses (IAV) remain emerging threats to human public health. Live-attenuated influenza vaccines (LAIV) are one of the most effective prophylactic options to prevent disease caused by influenza infections. However, licensed LAIV remain restricted for use in 2- to 49-year-old healthy and...
Autores principales: | Nogales, Aitor, Steel, John, Liu, Wen-Chun, Lowen, Anice C., Rodriguez, Laura, Chiem, Kevin, Cox, Andrew, García-Sastre, Adolfo, Albrecht, Randy A., Dewhurst, Stephen, Martínez-Sobrido, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241597/ https://www.ncbi.nlm.nih.gov/pubmed/35583364 http://dx.doi.org/10.1128/spectrum.00078-22 |
Ejemplares similares
-
Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine
por: Hilimire, Thomas A., et al.
Publicado: (2020) -
Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development
por: Lorenzo, María M., et al.
Publicado: (2022) -
A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity
por: Cox, Andrew, et al.
Publicado: (2020) -
Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine
por: Martínez-Sobrido, Luis, et al.
Publicado: (2018) -
A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines
por: White, Chantelle L., et al.
Publicado: (2021)